角膜新生血管
新生血管
氧化应激
材料科学
体内
药物输送
纳米颗粒
活性氧
药理学
纳米技术
癌症研究
化学
血管生成
医学
生物化学
生物
生物技术
作者
Kai Fan,Lixue Yu,Yuehuang Wu,Lan Zheng,Xiuqin Yang,Jingwei Lin,Mengyuan Wang,Yingyue Ye,Ruimiao Lin,Quancheng Chen,Zeyu Liu,Yuhua Xue,Jingjing Xie,Cheng Li
标识
DOI:10.1016/j.matdes.2023.112412
摘要
Corneal neovascularization is a severe eye disease that is often associated with an inflammatory cycle and increased oxidative stress. Excessive reactive oxygen species can cause harmful changes in the corneal epithelium and lead to vicious inflammatory cycles, resulting in an increase in corneal neovascularization. If left untreated, this can lead to corneal opacity and even blindness. Unfortunately, many drugs used to treat this condition are water-insoluble and have low bioavailability on the ocular surface, which limits their effectiveness. Therefore, it's crucial to design a new drug delivery system. In this study, researchers designed an oxide-responsive nanoparticle called M-SS-PDA to enhance drug efficacy. Under 40 mM H2O2 conditions, M-SS-PDA@ Fenofibrate exhibited a significantly ROS-responsive release behavior. In an in vivo study using mice, treatment with M-SS-PDA@ Fenofibrate resulted in minimal corneal neovascularization area and length and significantly reduced expression of pro-angiogenic factors and oxidative stress factors. Therefore, M-SS-PDA solves the problem of poor drug solubility and has the ability to release drugs in response to oxidation, clearing oxygen species in the pathological environment and releasing drugs in large amounts at the pathological site, which will improve its therapeutic effect in corneal neovascularization.
科研通智能强力驱动
Strongly Powered by AbleSci AI